We evaluated the gain in long-term survival of BDIX rats obtain a curative effect. A partial protection of the cured bearing DHDProB colon cancer developed in the peritoanimals against rechallenge with the parental cells was neal cavity after in vivo therapy with the tk gene and GCV.
Introduction
to a great extent on the strength of this bystander effect. Gene therapy of cancer is a very attractive approach for
As of June 1996, 20 proposals for tk-based gene therapy the treatment of cancer, based on the antitumor effects protocols had been submitted to the RAC. 1 Most of them observed in animal models. So far, phase I-II trials indiconcerned brain tumors for which preclinical studies had cate that gene therapy is safe. However, none of the curproved to be very promising. Results obtained in this rent clinical strategies has demonstrated real efficacy (for model of localized tumors led to an extension of the indireview see Roth and Cristiano 1 ). This is well illustrated cations to locoregional tumors developed in peritoneal or with the use of the herpes simplex virus thymidine kinpleural cavities. However, in these models, previously ase gene (tk) and ganciclovir treatment.
published animal studies do not highlight a decisive antiThe tk gene encodes for an enzyme involved in the tumor activity. [5] [6] [7] [8] [9] As a matter of fact, most of these studphosphorylation of an antiviral nucleoside, ganciclovir ies described a massive tumor killing activity but the sur-(GCV), that is not metabolized by mammalian cells. Thus vival time of the treated animals was not really GCV is not toxic under normal conditions whereas triimproved. 5, 6, 10 phosphorylated GCV can be incorporated into nascent
Our purpose was thus to analyze the long-term benefit DNA of the cycling cell and eventually results in its obtained after tk/GCV treatment in a model of intraperideath. GCV toxicity is not restricted to tk-expressing cells, toneal tumors. DHDProB cells (isolated from a chemiand several studies have reported the existence of a cally induced rat colon carcinoma) injected i.p. in a syn-'bystander' effect where only a small percentage of cells geneic host (BDIX rats) formed millions of nodules on need to be transduced with the tk gene to achieve effecthe inner face of the peritoneum. 11,12 These nodules were tive tumor eradication. [2] [3] [4] This is usually explained by the macroscopically observable 10 days after cell injection. diffusion of the toxin from one cell to another through Between day 40 and 60, the rats developed ascites and gap junctions, but some studies suggest that it may also died. Thus, this model mimicked the clinical presentation be due to an activation of the immune system or diffusion of intraperitoneal tumors in humans. of apoptotic vesicles. Since it is far beyond our abilities
We first determined the percentage of tk-expressing to introduce the therapeutic DNA in every single tumor cells necessary to induce a complete tumor regression after GCV treatment and the immune protection of the cured animals against parental cells. Based on these results, we finally designed a protocol of in vivo gene stably transfected with the tk gene and if at least 100 municate through gap junctions with an average of three to eight neighboring cells, depending on the confluency mg/kg/day of GCV were injected very rapidly after tumor cell implantation. Successful tk/GCV treatment of the colony (Figure 2 ). Compared with other cell lines for which the bystander effect was observed, such a comwas accompanied by a partial protection of the cured animals against parental cells. Nevertheless, at least 75% of munication capacity is low. 13 Thus, in this system, the toxic effect induced by GCV treatment of a mixed poputk-expressing cells were required to observe a therapeutic benefit, demonstrating a poor efficiency of the bystander lation containing tk-positive and negative cells correlated well with the capacity of these cells to share their load effect in vivo. In contrast, we showed that repeated ip injections of a solution of DOTAP and plasmids encoding of toxin by passive diffusion. for IL-2 and tk followed by GCV treatment had a strong antitumoral activity resulting from the combined toxic Long-term survival of tk/GCV treated animals effects of DNA/DOTAP and tk/GCV plus a potential Two million DHDProBtk + cells per rat were injected i.p. immune response mediated by IL-2.
at day 0. The animals were checked twice a week and killed when their ascites increased, with an average of 40 ml per ascite.
Results
The results presented in Table 1 indicate that GCV was efficient when the treatment started early (5 or 10 days Efficiency of tk/GCV treatment in vitro The mass culture of tk + DHDProB cells was incubated in after implantation of the cells) and with 100 mg/kg/day GCV (groups 2 and 4). The same treatment was inefthe presence of increasing concentrations of GCV, ranging from 10 −8 to 10 −5 m, and counted after 14 days in culficient when started at day 15 (group 6) or with a lower dose of GCV (50 mg/kg/day) (groups 1, 3 and 5). ture. The results indicated that 10 −6 m of GCV was sufficient to kill more than 95% of the cells (Figure 1a )
Animals who did not respond to GCV were killed and the presence of TK::ShBle fusion protein in the tumors whereas unmodified DHDProB cells were resistant to GCV at 10 −5 m (data not shown). was analyzed by immunolabeling with an antiShBle antibody. All tumors tested were negative, indicating that in In order to measure the bystander effect in vitro, mixed cultures containing DHDProB and increasing percentages these animals the developing tumor did not express detectable levels of the tk-gene any more. In addition, of DHDProBtk + cells were coincubated for 14 days in the presence of 5 × 10 −6 m of GCV. The results presented in most of these GCV-treated animals had necrotic foci in their liver, with macrophage infiltration in certain cases. Figure 1b showed that after GCV treatment, the death of one tk + cell was accompanied by the death of two This was not observed in the control rats without GCV treatment and suggested that massive death of tk-positive neighbor tk − cells. Diffusion of the tri-phosphorylated toxic form of GCV tumor cells after GCV treatment could be toxic. Two million DHDProB cells were reimplanted s.c. in through gap junctions could explain part of the bystander effect. Since the passive diffusion of one molecule five rats who survived after injection of 100 mg/kg/day of GCV at day 5 (from group 2, Table 1 ). Sixty-four days through gap junctions significantly varies from one cell line to another, we tested the capacity of the cells to comlater, one was still tumor-free, two had a very small tumor (8 and 125 mm   3 ) and the last two had medium municate through gap junctions by a dye transfer assay. This experiment indicated that one cell was able to comsize tumors (1000 and 2000 mm 3 ). Each of the four control vivo, is too weak to significantly modify the survival of the animals.
Combined tk and interleukin-2 treatment by direct injections of the DNA in vivo animals who received DHDProB cells s.c. for the first time developed tumors during the same period of time Our results indicated that tk/GCV could cure animals only when almost all the cells expressed the tk gene, and (2531 ± 1303 mm 3 ). Thus, tk/GCV-treated animals did resist rechallenge better than naive rats but the difference that treated animals could be partially immunized against rechallenge. is not statistically significant, suggesting a partial protection only.
We then designed an in vivo protocol in which the suicide effect was combined with a stimulation of the immune system. Two hundred micrograms of plasmids Evaluation of tk bystander effect in vivo To determine the percentage of tk-expressing cells necescoding for tk and IL-2 were injected i.p. in association with 400 g of DOTAP into BDIX rats bearing DHDProB sary to induce a complete rejection of a DHDProB tumor in vivo, different percentages of tk-positive and negative tumors implanted 5 days earlier. In these conditions, using the lacZ reporter gene, we established that most of cells were injected i.p. Five days later, the animals were treated with 100 mg/kg/day of GCV for 10 days. Sixtythe tumor nodules were weakly stained blue after X-gal staining. This staining was observed on the outer layers two days later, the number of survivors was evaluated. Table 2 indicates that in the presence of 90% of tkof the nodules (Figure 3 ). The animals were separated into five different groups expressing cells, the GCV treatment was efficient in three of six animals. The number of long-term survivors rap-( Figure 4 ): group 1: control without any treatment; group 2: four rats treated with pGL2 DNA (encoding for idly decreased to background levels as soon as less than 75% of tk-positive cells were injected. All the deaths were luciferase) and GCV; group 3: six rats treated with p-IL2 (no GCV); group 4: pUT599 (TK::ShBle) plus GCV and related to the growth of intraperitoneal tumors but not to the presence of distant metastasis. These results group 5: 100 g of pUT599 (TK::Sh) plus 100 g of p-IL2 and GCV. The DNA (200 g final) was injected 5 days demonstrated that the bystander effect, if it does exist in after tumor implantation, and the rats were then treated enough to mask any potential benefit gained from tk or IL-2 expression. for 10 days with 100 mg/kg/day with GCV, except for group 2 (treated with p-IL2). The same procedure (DNA In contrast, after a combination of tk and IL-2 DNA injections plus GCV treatments, three out of five animals injection and GCV) was repeated on day 19.
Injections of DOTAP and DNA improved the animals' remained disease-free until the end of this experiment at day 280. The survival curves were statistically different survival. The median survival time increased from 42 days in the control animals (group 1) to 138 days in between group 5 and control group 1 (P Ͻ 0.03), but not when compared with group 2 (P Ͼ 0.3). This indicated that group 2 (treated with an irrelevant DNA). No difference was observed in groups 3 and 4, with median survival the combined effects of DNA/DOTAP plus tk/GCV 'toxicities' in association with IL-2 in vivo expression significantly times of 141 and 90 days respectively, compared with group 2. Thus DOTAP/DNA association seemed to slow improved the number of event-free survivors, whereas each of these treatments used separately did not. down the tumor progression. This effect was strong ability to eradicate tk + tumors in vivo. Thus, the evaluation of the 'suicide' sensitivity as well as the communication capacity of the cells in vitro could give an interesting clue to extrapolate the success one can expect from a tk/GCV treatment in vivo.
TK and GCV association had significant toxic effects on the liver. Toxicity has also been observed and well documented in an ascites model of human breast cancer in nude mice. 5 In this system, in vivo tk gene transfer by intraperitoneal injection of adenovirus was associated with severe histological abnormalities in the liver due to the expression of the tk gene in normal liver. In our experiment, the tumor cells were tk-positive but not the normal tissues; thus the toxicity is more likely to be massive cell death following GCV injection. This immune response was not able to protect every animal, and usually resulted in a decrease of the growth rate of the Discussion tumors rather than a complete protection. These results are too preliminary to discuss the nature and the imporSuicide gene therapy was initially described as a powerful experimental treatment for brain cancer, 14 and since tance of this protection. This point is currently being examined in a larger number of animals. Altogether, that time tk/GCV antitumor activity has been firmly affirmed in localized tumors such as brain cancers or liver these results demonstrated that, in this model, a tk/GCV association was not an appropriate treatment to envisage metastases of colon carcinoma. Nevertheless, it is not clear at this time whether or not the antitumor activity for gene therapy. They also suggested that a combination treatment able to reinforce the antitumor immunity genof suicide genes can be associated with an increase in the long-term survival of animals in other models of cancers erated by the tk/GCV activity could lead to a better response. localized in the peritoneal or pleural cavities. Our study aimed to answer this question in a model of colon tumors Le Pendu et al 15 reported that live IL-2-expressing DHDProB cells are less tumorigenic and stimulate an disseminated in the peritoneum of syngeneic rats.
Since the success of the use of 'suicide gene therapy' immune response against parental DHDProB cells. This vaccination effect was no longer observed when the ILdepends to a great extent on the strength of the bystander effect, we first measured it in vitro and in vivo.
2-expressing cells were irradiated before injection. It was also established that DHDProB cells expressed tumor In our DHDProB model, the stable expression of the tk gene rendered the cells sensitive to at least 1 m GCV antigens (TAA) but no class II MHC molecules. 12 Nevertheless, the analysis of tumor sections revealed the pres-(2.5 g/ml). This concentration corresponded to a relatively high dose of GCV when compared with other pubence of dendritic cells expressing high levels of MHCII molecules within the tumors. These dendritic cells could lished results showing that sensitive cells like NIH3T3 died when incubated with 0.1 g/ml GCV and resistant be involved in the presentation of TAA in association with MHC class I or II molecules, since these cells were cell lines needed up to 25 g/ml.
4 This low sensitivity was associated with a moderate bystander effect in vitro able to stimulate tumor-immune T cells in vitro. It has been established that the transfer of a plasmid encoding (33% of transduced versus nontransduced cells) compared with the one demonstrated in mesotheliomas (10%) or in for IL-2 into the tumors was synergistic with tk and induced a systemic antitumor immunity that resulted in other systems. 13 In other words, one tk-positive cell killed two neighboring cells while, under the same conditions, the regression of tumors as well as a protection against challenges of parental tumor cell. 10, 16 It was then reasonthe diffusion of a dye through gap junctions showed that one cell communicated with three to eight surrounding able to assume that local secretion of IL-2 by transfected tumor cells could make a difference by strengthening the cells. Thus, the bystander effect was proportional to the number of communicating cells. These weak sensitivity immune response, rendering it fully functional. In the last part of our study different plasmids were injected i.p. in and bystander effects were even less pronounced in vivo, since we showed that 100 mg/kg/day GCV were needed association with DOTAP. The results indicated that repeated injections of DNA encoding for luciferase with to cure the animals if 100% of the cells expressed the tk gene, and that the presence of more than 75% of tk-DOTAP were able to slow down the tumor progression. When the injected DNA encoded for IL-2 or tk (followed expressing cells was necessary to observe a curative effect. These results are in agreement with those by GCV treatment in this case), no further benefit was observed. By contrast, when the plasmid encoding for ILdescribed by Beck and collaborators 4 who established that the sensitivity to GCV in vitro correlated with the 2 was injected in addition to the tk/GCV treatment, three out of five animals remained disease-free. The ILmm). The DHDProB cell line was transfected in vitro in 100 mm Tissue Culture-treated Petri dishes with 8 g 2/tk/GCV treatment statistically improved the behavior of the animal when compared with untreated animals but pUT599 plasmid using DOTAP (Boehringer Mannheim, Meylan France), and selected for 2 weeks in the presence not when compared with the other groups which received DOTAP and DNA. Our hypothesis is that this of 300 g/ml of Zeocin (Cayla). A mass culture of tk + cells was obtained in which all the cells stained positively improvement is the result of the combined effects of the DNA/DOTAP toxicity, the local IL-2 expression and of with the rabbit anti-Sh-Ble polyclonal antibody (Cayla).
For in vitro determination of GCV sensitivity, cells were the tk/GCV activity. In the colon carcinoma studies, the tk and IL-2 genes transferred by adenoviruses 10, 16 cultured in six-well plates and incubated for 14 days in the presence of 10 −8 to 10 −6 m ganciclovir (Cymevan; increased the survival time of the animals, but none of them remained disease-free. These authors established Roche, Neuilly sur Seyne, France). The cells were then trypsinized and counted. that the antitumor activity was mediated by CD8 + T lymphocytes, but that this immunity rapidly waned over time resulting in the death of the animals after tumor Dye-transfer assay to measure the gap junctional recurrence. The highest number of survivors in our intercellular communication capacity model is hardly explicable by a better transfection
To estimate the gap junctional intercellular communiefficiency of DOTAP compared with adenoviruses. Our cation capacity of the cells, 5% (wt/vol) of fluorescent hypothesis is that large quantities of DOTAP could have dye, lucifer yellow CH (Sigma), in 0.33 m lithium chloride an adjuvant effect when associated with DNA. In a conwas transferred to a glass needle prepared from capillary text of important tumor cell lysis and in the presence of tube (A-M Systems, Everett, WA, USA). Cells of confluent IL-2, this adjuvant effect could be strong enough finally cultures were impaled with needles and the dye was to cross the threshold and induce a protective immunity.
injected continuously for 0.8 s under air pressure (200-In addition, the second injection of DOTAP/DNA at day 400 hPa), by using an Eppendorf microinjector (model 19 could have also participated in the long-lasting effect 5242; Hamburg, Germany). After 10 min, the intercellular of this immune protection by maintaining high levels of transfer of lucifer yellow was estimated by counting the antitumor protection and preventing tumor recurrence.
fluorescent cells under an Olympus IMT-2 (OSI, LimonDifferent studies demonstrated the existence of a est, France) phase-contrast/fluorescent microscope. The powerful tk/GCV antitumor activity in intraperitoneal number of communicating cells per injection was models including human breast cancer in nude mice, 5 presented as an average of at least 15 microinjections. colon carcinoma in BALB/c mice 10, 16 and mesotheliomas Photographs of microinjections were taken using Ilford in SCID mice, 8, 9 or in immunocompetent rats. 6 All of HP5 (ASA 400) films (Anitec, St Priest, France). them established a pronounced decrease in tumor size after tk/GCV treatments, but the gain in survival time Establishment of peritoneal tumors (when this question was addressed) increased from 25 to Two million DHDProB cells in 2 ml serum-free medium 32 days (breast), 26 to 34 (mesothelioma) and was not were injected intraperitoneally in 8-week-old female changed in the colon carcinoma model. 10 This clearly sug-BDIX rats (IFFA-CREDO, Marcy l'Etoile, France). If the gests that even if a strong reduction in the tumor burden animals appeared moribund, unable to feed, or had too is achieved by tk/GCV treatment, other parameters such big ascites, they were killed and this was recorded as the as the clinical presentation, variations of sensitivity date of death. When indicated in the text, 50 or 100 and/or immunogenicity will render the recovery a gammg/kg/day of ganciclovir were injected i.p. (twice a day ble. In vitro analysis can help to foresee the opportunity for 10 days). to start a tk treatment, but in any case the combination of suicide effect and immunostimulation seems to be X-gal histochemistry indicated.
Tissues recovered from killed rats were fixed at 4°C in 2% formaldehyde, 2% glutaraldehyde for 1 h, rinsed in PBS and incubated overnight at 30°C in 5 mm K 3 Fe(CN) 6 ,
Materials and methods
5 mm K 4 Fe(CN) 6 , 2 mm MgCl 2 , 1 mg/ml 5-bromo4chloro3-indolyl-␤-galactopyranoside (X-gal). Tissues Plasmids were then rinsed in PBS, post-fixed in 10% formamide Plasmid pUT599 (Cayla, Toulouse, France) contains a overnight at room temperature and embedded in paraf-TK::Sh fusion gene allowing a stable expression of both fin. Thick sections (10 m) were then evaluated for ␤-thymidine-kinase and Zeocin resistance. Its expression is galactosidase expression using a magnification of 10. driven by the viral herpes simplex thymidine kinase promoter and the viral polyoma Py F441 enhancer. Statistics The pGL2 plasmid was obtained from Promega
Comparison of treatment versus control survival data was (Charbonnières, France) and the plasmid encoding for rat performed by use of a log-rank test. IL-2 was a kind gift of Dr Le Pendu. 15 Plasmid pSV␤ encoding for ␤-galactosidase was obtained from Clontech (Palo Alto, CA, USA 
